FASLODEX Side Effects

6388627-1 | Cellulitis, Culture Wound Positive, Injection Site Reaction, Injection Site Swelling, Skin Necrosis, Staphylococcal Infection, Wound Necrosis
on Sep 25, 2009 Female patient from TAIWAN, PROVINCE OF CHINA , 50 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), culture wound positive, injection site reaction, injection site swelling, skin necrosis, staphylococcal infection (What is staphylococcal infection?), wound necrosis. Faslodex dosage: 500 Mg 2 Sites Of Her Buttock. Patient was hospitalized.

6386874-6 | Nephrolithiasis
Patient was taking Faslodex (View Usage). Patient had the following side effects: nephrolithiasis on Sep 23, 2009 from UNITED STATES Additional patient health information: Female patient , 55 years of age, was diagnosed with breast cancer metastatic, diabetes mellitus, pancreatolithiasis, neuropathy peripheral, pain (What is pain?) and. Faslodex dosage: Once A Month. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), CREON (View Creon Review and Creon Label ), LYRICA (View Lyrica Review and Lyrica Label ), NORFLEX (View Norflex Review and Norflex Label ), MOBIC (View Mobic Review and Mobic Label ), K SUPPLEMENT (View K Supplement Review and K Supplement Label ).

6379662-8 | Dehydration, Nausea
Adverse event was reported on Sep 24, 2009 by a Female patient taking Faslodex (View Usage) (Dosage: 500mg Day1,14,28) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 40 years of age, weighting 179.9 lb, After Faslodex was administered, patient had the following side effects: dehydration, nausea (What is nausea?). During the same period patient was treated with RAD001 (5mg Po Daily) (View Rad001 Review and Rad001 Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), PERI COLACE (View Peri-colace Review and Peri-colace Label ). Patient was hospitalized.

6379660-4 | Dehydration, Metastases To Bone, Nausea
on Sep 24, 2009 Female patient from UNITED STATES , 40 years of age, weighting 179.9 lb, was diagnosed with breast cancer metastatic and was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, metastases to bone, nausea (What is nausea?). Faslodex dosage: 250 Mgdays 14, 28 Im (30. During the same period patient was treated with RAD001 (Rad001 5 Mg Daily Po (047)) (View Rad001 Review and Rad001 Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), PERI COLACE (View Peri-colace Review and Peri-colace Label ). Patient was hospitalized.


6354845-1 | Nail Disorder, Renal Failure
on Sep 03, 2009 Female patient from UNITED STATES , weighting 272.9 lb, was diagnosed with renal disorder, pain (What is pain?), hypothyroidism and was treated with Faslodex (View Usage). Patient had the following side effects: nail disorder, renal failure. Faslodex dosage: 250 Mg/5ml. During the same period patient was treated with PHOSLO (View Phoslo Review and Phoslo Label ), VICODIN (View Vicodin Review and Vicodin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), CALCIUM (View Calcium Review and Calcium Label ). Patient was hospitalized.

6348752-8 | Interstitial Lung Disease
Patient was taking Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: interstitial lung disease on Sep 02, 2009 from SPAIN Additional patient health information: Female patient , 63 years of age, was diagnosed with breast cancer metastatic and. Faslodex dosage: . During the same period patient was treated with TAXOTERE (80 Mg 1 Vial 2 Ml; 148 Mg Cyclic) (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

6337496-4 | Lithotripsy, Nephrolithiasis
Adverse event was reported on Aug 24, 2009 by a Female patient taking Faslodex (View Usage) (Dosage: ) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 53 years of age, weighting 203.9 lb, Patient experienced the following unwanted or unexpected effects: lithotripsy, nephrolithiasis. During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), LYRICA (View Lyrica Review and Lyrica Label ), AREDIA (View Aredia Review and Aredia Label ), INSULIN (View Insulin Review and Insulin Label ), CALCIUM SUPPLEMENT (View Calcium Supplement Review and Calcium Supplement Label ).

6307410-6 | Hallucination, Tactile, Hallucination, Visual, Vertigo
on Aug 10, 2009 Female patient from UNITED STATES , weighting 182.1 lb, was diagnosed with breast cancer (What is breast cancer?), blood cholesterol, thyroid disorder, cardiac disorder, blood pressure management and was treated with Faslodex (View Usage). Patient had the following side effects: hallucination, tactile, hallucination, visual, vertigo. Faslodex dosage: . During the same period patient was treated with ZETIA (View Zetia Review and Zetia Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), TRIAMTERENE (View Triamterene Review and Triamterene Label ).

6298130-5 | Gastric Ulcer Perforation, Obstructive
on Jul 27, 2009 Female patient from FRANCE , 79 years of age, weighting 130.1 lb, was diagnosed with breast cancer metastatic, bone cancer metastatic and was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: gastric ulcer perforation, obstructive. Faslodex dosage: . During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ). Patient was hospitalized.

6296063-1 | Asphyxia, Chills, Cold Sweat, Dyspnoea
Patient was taking Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: asphyxia, chills, cold sweat, dyspnoea on Jul 31, 2009 from RUSSIAN FEDERATION Additional patient health information: Female patient , weighting 216.1 lb, was diagnosed with breast cancer (What is breast cancer?), metastases to bone and. Faslodex dosage: 250 Mg/5ml One Per Month.

6288995-5 | Decreased Appetite, Dyskinesia, Hot Flush, Influenza Like Illness, Memory Impairment, Muscle Spasms, Nausea, Oropharyngeal Pain, Somnolence
Adverse event was reported on Jul 21, 2009 by a Female patient taking Faslodex (View Usage) (Dosage: 2nd Dose Was 1/2 Of An Injection; Considering Full Dose For 3rd Dose) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 70 years of age, Patient had the following side effects: decreased appetite, dyskinesia, hot flush, influenza like illness, memory impairment, muscle spasms, nausea (What is nausea?), oropharyngeal pain, somnolence. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), THYROID PILL (View Thyroid Pill Review and Thyroid Pill Label ).

6265273-1 | Blood Calcium Increased, Lethargy
on Jun 30, 2009 Female patient from UNITED KINGDOM , 78 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: blood calcium increased, lethargy. Faslodex dosage: . Patient was hospitalized.

6238813-6 | Gastric Ulcer Perforation, Obstructive
on Jun 11, 2009 Female patient from FRANCE , 79 years of age, was diagnosed with breast cancer female and was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: gastric ulcer perforation, obstructive. Faslodex dosage: . During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ). Patient was hospitalized.

6233464-1 | Dysgeusia, Dyspnoea
Patient was taking Faslodex (View Usage). Patient had the following side effects: dysgeusia, dyspnoea on Jun 10, 2009 from GERMANY Additional patient health information: Female patient , weighting 176.4 lb, was diagnosed with breast cancer metastatic and. Faslodex dosage: Third Application.

6232879-5 | Hypersexuality, Insomnia, Mania, Tachyphrenia
Adverse event was reported on Apr 20, 2009 by a Female patient taking Faslodex (View Usage) (Dosage: ) . Location: UNITED STATES , 54 years of age, weighting 130.1 lb, After Faslodex was administered, patient had the following side effects: hypersexuality, insomnia, mania, tachyphrenia. During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), EFFEXOR XR (View Effexor Xr Review and Effexor Xr Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ).

6232878-3 | Hyperkeratosis
on Apr 13, 2009 Female patient from UNITED STATES , 58 years of age, was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkeratosis. Faslodex dosage: .

6232875-8 | Arthralgia, Malaise, Myalgia, Pain
on Apr 01, 2009 Female patient from UNITED STATES , 70 years of age, was treated with Faslodex (View Usage). Patient had the following side effects: arthralgia, malaise, myalgia, pain (What is pain?). Faslodex dosage: . During the same period patient was treated with VITAMIN E (View Vitamin E Review and Vitamin E Label ), ZOMETA (View Zometa Review and Zometa Label ).

6232874-6 | Disease Progression
Patient was taking Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: disease progression on Mar 26, 2009 from UNITED STATES Additional patient health information: Female patient , 51 years of age, . Faslodex dosage: .

6232873-4 | Back Pain, Bone Pain, Fibromyalgia, Oropharyngeal Pain
Adverse event was reported on Mar 19, 2009 by a Female patient taking Faslodex (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 49 years of age, Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), bone pain, fibromyalgia, oropharyngeal pain. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ).

6232872-2 | Tumour Marker Increased
on Mar 13, 2009 Female patient from UNITED STATES , 56 years of age, weighting 175.0 lb, was treated with Faslodex (View Usage). Patient had the following side effects: tumour marker increased. Faslodex dosage: .

6232871-0 | Epistaxis, Fatigue
on Feb 25, 2009 Female patient from UNITED STATES , 64 years of age, was diagnosed with breast cancer recurrent and was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: epistaxis, fatigue. Faslodex dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ).

6232869-2 | Abnormal Faeces, Hair Disorder, Urine Odour Abnormal
Patient was taking Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal faeces, hair disorder, urine odour abnormal on Mar 04, 2009 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 149.9 lb, was diagnosed with breast cancer (What is breast cancer?) and. Faslodex dosage: . During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ), AROMASIN (View Aromasin Review and Aromasin Label ).

6232868-0 | Alopecia, Hot Flush
Adverse event was reported on Feb 26, 2009 by a Female patient taking Faslodex (View Usage) (Dosage: ) was diagnosed with pain (What is pain?), hypertension, cardiac disorder, osteoporosis (What is osteoporosis?), hypothyroidism and. Location: UNITED STATES , 80 years of age, weighting 132.1 lb, Patient had the following side effects: alopecia, hot flush. During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), NORVASC (View Norvasc Review and Norvasc Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), ISOSORBIDE (View Isosorbide Review and Isosorbide Label ), ACTONEL (View Actonel Review and Actonel Label ), LEVOTHROID (View Levothroid Review and Levothroid Label ).

6232867-9 | Abasia, Constipation, Injection Site Discomfort, Muscular Weakness, Walking Aid User
on Feb 26, 2009 Female patient from UNITED STATES , 67 years of age, weighting 103.0 lb, was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: abasia, constipation (What is constipation?), injection site discomfort, muscular weakness, walking aid user. Faslodex dosage: . During the same period patient was treated with REGLAN (View Reglan Review and Reglan Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

6232865-5 | Blood Glucose Increased, Injection Site Discomfort
on Feb 17, 2009 Female patient from UNITED STATES , 72 years of age, weighting 123.9 lb, was diagnosed with breast cancer recurrent, hypertension, osteoporosis (What is osteoporosis?), blood cholesterol increased and was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, injection site discomfort. Faslodex dosage: . During the same period patient was treated with AVAPRO (View Avapro Review and Avapro Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6232863-1 | Decreased Appetite, Nausea
Patient was taking Faslodex (View Usage). Patient had the following side effects: decreased appetite, nausea (What is nausea?) on Jan 21, 2009 from UNITED STATES Additional patient health information: Female patient , 68 years of age, weighting 121.0 lb, was diagnosed with breast cancer metastatic, pain (What is pain?) and. Faslodex dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), ZOMETA (View Zometa Review and Zometa Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), COZAAR (View Cozaar Review and Cozaar Label ), NORVASC (View Norvasc Review and Norvasc Label ).

6232861-8 | Breast Cancer Metastatic
Adverse event was reported on Dec 22, 2008 by a Female patient taking Faslodex (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 71 years of age, After Faslodex was administered, patient had the following side effects: breast cancer metastatic.

6232859-X | Arthritis, Injection Site Irritation, Musculoskeletal Pain
on Dec 08, 2008 Female patient from UNITED STATES , 61 years of age, was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), injection site irritation, musculoskeletal pain. Faslodex dosage: .

6232858-8 | Aphonia
on Jan 05, 2009 Female patient from UNITED STATES , 40 years of age, weighting 241.0 lb, was diagnosed with breast cancer metastatic, breast cancer female and was treated with Faslodex (View Usage). Patient had the following side effects: aphonia. Faslodex dosage: . During the same period patient was treated with NAVALENE (Weekly) (View Navalene Review and Navalene Label ), AVASTIN (Weekly) (View Avastin Review and Avastin Label ), TAXOL (Daily) (View Taxol Review and Taxol Label ).

6232857-6 | Influenza Like Illness, Nasal Congestion
Patient was taking Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: influenza like illness, nasal congestion on Dec 03, 2008 from UNITED STATES Additional patient health information: Female patient , 81 years of age, weighting 130.1 lb, was diagnosed with neoplasm malignant and. Faslodex dosage: .

6232856-4 | Dizziness, Nausea, Pain In Jaw, Product Taste Abnormal
Adverse event was reported on Dec 11, 2008 by a Female patient taking Faslodex (View Usage) (Dosage: 260 Mg/5cc, Monthly) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 63 years of age, weighting 142.0 lb, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), nausea (What is nausea?), pain in jaw, product taste abnormal. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6232855-2 | Tumour Marker Increased
on Nov 03, 2008 Female patient from UNITED STATES , 74 years of age, was treated with Faslodex (View Usage). Patient had the following side effects: tumour marker increased. Faslodex dosage: . During the same period patient was treated with RITUXAN (View Rituxan Review and Rituxan Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ).

6232852-7 | Alopecia
on Oct 04, 2008 Female patient from UNITED STATES , 47 years of age, was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: alopecia. Faslodex dosage: .

6232851-5 | Dysphonia, Fatigue, Headache, Hot Flush, Oropharyngeal Pain
Patient was taking Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: dysphonia, fatigue, headache (What is headache?), hot flush, oropharyngeal pain on Oct 03, 2008 from UNITED STATES Additional patient health information: Female patient , 73 years of age, was diagnosed with breast cancer metastatic and. Faslodex dosage: .

6232849-7 | Hypoaesthesia Facial
Adverse event was reported on Sep 26, 2008 by a Female patient taking Faslodex (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 64 years of age, weighting 149.9 lb, Patient had the following side effects: hypoaesthesia facial. During the same period patient was treated with TOLAZAMIDE (View Tolazamide Review and Tolazamide Label ), VYTORIN (View Vytorin Review and Vytorin Label ), PROZAC (View Prozac Review and Prozac Label ).

6232848-5 | Prothrombin Time Prolonged
on Sep 24, 2008 Male patient from UNITED STATES , 81 years of age, weighting 170.0 lb, was diagnosed with breast cancer male and was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: prothrombin time prolonged. Faslodex dosage: .

6232847-3 | Back Pain, Diarrhoea, Dyspepsia
on Sep 15, 2008 Female patient from UNITED STATES , 69 years of age, was diagnosed with breast cancer (What is breast cancer?), diarrhoea and was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), diarrhoea, dyspepsia. Faslodex dosage: . During the same period patient was treated with TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), IMODIUM (View Imodium Review and Imodium Label ), LOVAZA (View Lovaza Review and Lovaza Label ).

6232846-1 | Burning Sensation, Pain, Paraesthesia
Patient was taking Faslodex (View Usage). Patient had the following side effects: burning sensation, pain (What is pain?), paraesthesia on Sep 05, 2008 from UNITED STATES Additional patient health information: Female patient , 49 years of age, was diagnosed with sarcoma uterus and. Faslodex dosage: . During the same period patient was treated with LUPRON (View Lupron Review and Lupron Label ).

6232845-X | Injection Site Reaction
Adverse event was reported on Aug 19, 2008 by a Female patient taking Faslodex (View Usage) (Dosage: 250 Mg) was diagnosed with breast cancer metastatic and. Location: UNITED STATES , 56 years of age, After Faslodex was administered, patient had the following side effects: injection site reaction.

6232843-6 | Blood Glucose Abnormal
on Jul 31, 2008 Female patient from UNITED STATES , 67 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose abnormal. Faslodex dosage: .

6232841-2 | Dry Skin
on Jul 10, 2008 Female patient from UNITED STATES , 74 years of age, weighting 208.1 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Faslodex (View Usage). Patient had the following side effects: dry skin. Faslodex dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ).

6232840-0 | Alopecia
Patient was taking Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: alopecia on Jun 25, 2008 from UNITED STATES Additional patient health information: Female patient , 38 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Faslodex dosage: .

6232839-4 | Dizziness, Dysgeusia, Feeling Abnormal, Flushing, Paraesthesia Oral
Adverse event was reported on Jun 24, 2008 by a Female patient taking Faslodex (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 66 years of age, weighting 143.1 lb, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), dysgeusia, feeling abnormal, flushing, paraesthesia oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), CALCIUM (View Calcium Review and Calcium Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

6232838-2 | Anxiety, Blood Pressure Increased, Constipation, Feeling Abnormal, Hot Flush, Nausea, Nervousness, Palpitations, Panic Attack
on Jun 13, 2008 Female patient from UNITED STATES , 74 years of age, weighting 108.0 lb, was diagnosed with breast cancer metastatic and was treated with Faslodex (View Usage). Patient had the following side effects: anxiety (What is anxiety?), blood pressure increased, constipation (What is constipation?), feeling abnormal, hot flush, nausea (What is nausea?), nervousness, palpitations, panic attack. Faslodex dosage: . During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), XANAX (View Xanax Review and Xanax Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), ALLEGRA (View Allegra Review and Allegra Label ).

6232837-0 | Blood Pressure Increased, Chest Discomfort, Dizziness, Dyspnoea, Feeling Hot
on Aug 21, 2008 Female patient from UNITED STATES , 66 years of age, weighting 129.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: blood pressure increased, chest discomfort, dizziness (What is dizziness?), dyspnoea, feeling hot. Faslodex dosage: 250 Mg.

6232836-9 | Injection Site Pain, Urinary Tract Infection, Urine Odour Abnormal
Patient was taking Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: injection site pain, urinary tract infection (What is urinary tract infection?), urine odour abnormal on Jun 05, 2008 from UNITED STATES Additional patient health information: Female patient , 75 years of age, . Faslodex dosage: 250 Mg 1 X 5.0 Ml. During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ), CALTRATE (View Caltrate Review and Caltrate Label ).

6232834-5 | Asthenia, Fatigue, High Density Lipoprotein Decreased, Ill-defined Disorder
Adverse event was reported on May 14, 2008 by a Female patient taking Faslodex (View Usage) (Dosage: ) was diagnosed with breast cancer stage i and. Location: UNITED STATES , 74 years of age, weighting 123.0 lb, Patient had the following side effects: asthenia, fatigue, high density lipoprotein decreased, ill-defined disorder. During the same period patient was treated with LEVSIN (View Levsin Review and Levsin Label ).

6232833-3 | Anorexia, Weight Decreased
on May 06, 2008 Female patient from UNITED STATES , 72 years of age, weighting 144.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Faslodex (View Usage). After Faslodex was administered, patient had the following side effects: anorexia, weight decreased. Faslodex dosage: . During the same period patient was treated with ARIMIDEX (View Arimidex Review and Arimidex Label ).

6232831-X | Oral Pain, Oropharyngeal Blistering
on Feb 25, 2008 Female patient from UNITED STATES , 63 years of age, was treated with Faslodex (View Usage). Patient experienced the following unwanted or unexpected effects: oral pain, oropharyngeal blistering. Faslodex dosage: . During the same period patient was treated with BLOOD PRESSURE MEDICINE (View Blood Pressure Medicine Review and Blood Pressure Medicine Label ), IRON (View Iron Review and Iron Label ), VITAMINS (View Vitamins Review and Vitamins Label ).

6231009-3 | Thrombocytopenia
Patient was taking Faslodex (View Usage). Patient had the following side effects: thrombocytopenia on Jun 11, 2009 from COLOMBIA Additional patient health information: Male patient , 68 years of age, weighting 149.9 lb, was diagnosed with breast cancer metastatic, metastases to bone and. Faslodex dosage: . During the same period patient was treated with ZOMETA (View Zometa Review and Zometa Label ). Patient was hospitalized.